Full Year 2024 Select, Preliminary, Unaudited Financial Results…Sees revenue of approximately $693M, representing approximately 30% growth year-over-year;Continued improvement in adjusted EBITDA compared to the prior year… sees Q EPS , consensus
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEM:
- Tempus AI teams with Genialis to develop RNA-based biomarker algorithms
- Tempus AI up after FDA issues draft guidance on AI use in drug decision making
- tempus AI Inc Class A call volume above normal and directionally bullish
- Cathie Wood’s ARK Investment bought 348K shares of Tempus AI today
- Cathie Wood’s ARK Investment bought 335.7K shares of Tempus AI today